RHONDA HICKMAN: Open Payments
NPI 1992177463 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,352 in 158 payments from 24 companies in 2025. Trend: 2023 $3,115 · 2024 $4,454 · 2025 $3,352
Food & beverage: $3,352
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $520 |
| GlaxoSmithKline, LLC. | 28 | $373 |
| Inspire Medical Systems, Inc. | 5 | $281 |
| HARMONY BIOSCIENCES LLC | 9 | $254 |
| GENZYME CORPORATION | 10 | $245 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $192 |
| Regeneron Healthcare Solutions, Inc. | 8 | $191 |
| Merck Sharp & Dohme LLC | 8 | $180 |
| Electromed, Inc. | 10 | $166 |
| ANI Pharmaceuticals, Inc. | 5 | $131 |
Products named: DUPIXENT, INSPIRE, WAKIX, BREZTRI, FASENRA, TRELEGY ELLIPTA, NUCALA, SMARTVEST.
Industry payments across MS — which companies pay providers there.
